XML 112 R76.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Numerator:        
Net income attributable to Biogen Inc. $ 1,494.1 $ 866.6 $ 2,902.9 $ 2,039.5
Weighted-average shares used in calculating:        
Weighted average number of common shares outstanding 190.3 207.1 193.4 209.2
Effect of dilutive securities:        
Dilutive potential common shares 0.1 0.2 0.3 0.3
Shares used in calculating diluted earnings per share 190.4 207.3 193.7 209.5
Stock options and employee stock purchase plan        
Effect of dilutive securities:        
Stock units 0.0 0.0 0.0 0.0
Time-vested restricted stock units        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.2 0.2
Market stock units        
Effect of dilutive securities:        
Stock units 0.0 0.1 0.1 0.1
Performance stock units settled in stock        
Effect of dilutive securities:        
Stock units 0.0 0.0 0.0 0.0